Paediatric reference values for total psoas muscle area

Eberhard Lurz, Hiten Patel, Gerald Lebovic, Claudia Quammie, Jessica P Woolfson, Manuela Perez, Amanda Ricciuto, Paul W Wales, Binita M Kamath, Govind B Chavhan, Peter Jüni, Vicky L Ng, Eberhard Lurz, Hiten Patel, Gerald Lebovic, Claudia Quammie, Jessica P Woolfson, Manuela Perez, Amanda Ricciuto, Paul W Wales, Binita M Kamath, Govind B Chavhan, Peter Jüni, Vicky L Ng

Abstract

Background: Sarcopenia, the unintentional loss of skeletal muscle mass, is associated with poor outcomes in adult patient populations. In adults, sarcopenia is often ascertained by cross-sectional imaging of the psoas muscle area (PMA). Although children with chronic medical illnesses may be at increased risk for muscle loss because of nutritional deficiencies, physical deconditioning, endocrine anomalies, and systemic inflammation, consistent quantitative definitions for sarcopenia in children are lacking. We aimed to generate paediatric reference values for PMA at two intervertebral lumbar levels, L3-4 and L4-5.

Methods: In this cross-sectional study, we analysed abdominal computed tomography scans of consecutive children presenting to the emergency department. Participants were children 1-16 years who required abdominal cross-sectional imaging after paediatric trauma between January 1, 2005 and December 31, 2015 in a large Canadian quaternary care centre. Children with a documented chronic medical illness or an acute spinal trauma at presentation were excluded. Total PMA (tPMA) at levels L3-4 and L4-5 were measured in square millimetres (mm2 ) as the sum of left and right PMA. Age-specific and sex-specific tPMA percentile curves were modelled using quantile regression.

Results: Computed tomography images from 779 children were included. Values of tPMA at L4-5 were significantly larger than at L3-4 at all ages, but their correlation was high for both girls (r = 0.95) and boys (r = 0.98). Amongst girls, tPMA 50th percentile values ranged from 365 to 2336 mm2 at L3-4 and from 447 to 2704 mm2 for L4-5. Amongst boys, 50th percentile values for tPMA ranged between 394 and 3050 mm2 at L3-4 and from 498 to 3513 mm2 at L4-5. Intraclass correlation coefficients were excellent at L3-4 (0.97, 95% CI 0.94 to 0.981) and L4-5 (0.99, 95% CI 0.986 to 0.995). Weight and tPMA were correlated, stratified by sex for boys (L3-4 r = 0.90; L4-5 r = 0.90) and for girls (L3-4 r = 0.87; L4-5 r = 0.87). An online application was subsequently developed to easily calculate age-specific and sex-specific z-scores and percentiles.

Conclusions: We provide novel paediatric age-specific and sex-specific growth curves for tPMA at intervertebral L3-4 and L4-5 levels for children between the ages of 1-16 years. Together with an online tool (https://ahrc-apps.shinyapps.io/sarcopenia/), these tPMA curves should serve as a reference enabling earlier identification and targeted intervention of sarcopenia in children with chronic medical conditions.

Keywords: Children; Chronic Disease; Sarcopenia.

Conflict of interest statement

Eberhard Lurz has received speaker honoraria from Nutricia and Abbvie, but there is no conflict with this manuscript. Binita Kamath has received an unrestricted educational grant from Mirum. She is a consultant for Mirum, Shire, and DCI. None of these activities are in conflict with this manuscript. Peter Jüni serves as unpaid member of the steering group of trials funded by Astra Zeneca, Biotronik, Biosensors, St. Jude Medical, and The Medicines Company and has received research grants to the institution from Astra Zeneca, Biotronik, Biosensors International, Eli Lilly, and The Medicines Company and honoraria to the institution for participation in advisory boards from Amgen but has not received personal payments by any pharmaceutical company or device manufacturer. Vicky L. Ng is a consultant for Albireo, but there is no conflict with this manuscript. Hiten Patel, Gerald Lebovic, Claudia Quammie, Jessica P. Woolfson, Manuela Perez, Amanda Ricciuto, Paul W. Wales, and Govind B. Chavhan declare that they have no conflict of interest.

© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Figures

Figure 1
Figure 1
Axial and sagittal images. Lumbar levels were determined on (A) sagittal computed tomography images, enabling identification of the L3–4 and L4–5 intervertebral levels (yellow lines). (B) The axial images corresponding to these levels were then examined to determine the psoas muscle area (red lines).
Figure 2
Figure 2
Weight distribution curves stratified by sex. Weight distribution curves (5th to 95th percentile) for (A) male and (B) female participants from the Hospital for SickKids (dashed lines) are compared with Center for Disease Control (CDC) growth charts (full lines). Weight curves differ significantly (P < 0.0001) for male and female participants, with this study's cohort being slightly heavier.
Figure 3
Figure 3
Total psoas muscle area (tPMA) at lumbar level L3–4 showing 5th to 95th percentiles for (A) male and (B) female participants. tPMA values at L3–4 increases with patient age.
Figure 4
Figure 4
Total psoas muscle area (tPMA) at lumbar level L4–5 showing 5th to 95th percentiles for (A) male and (B) female participants. tPMA values at L4–5 increases with patient age.
Figure 5
Figure 5
Correlations of weight and total psoas muscle area (tPMA) at lumbar levels L3–4 and L4–5 stratified by sex. Weight and tPMA highly correlate for male and female participants at L3–4 and L4–5, respectively. (Pearson's correlation coefficient r = 0.90 for boys at L3–4 and L4–5 and r = 0.87 for girls at L3–4 and L4–5). Upper and lower dashed lines represent upper and lower boundaries of the 95% reference range.

References

    1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997;127, 990:s‐1, s.
    1. Carvalho do Nascimento PR, Poitras S, Bilodeau M. How do we define and measure sarcopenia? Protocol for a systematic review. Syst Rev 2018;7:51.
    1. Beaudart C, McCloskey E, Bruyere O, Cesari M, Rolland Y, Rizzoli R, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr 2016;16:170.
    1. Sevilla WMA. Nutritional considerations in pediatric chronic disease. Pediatr Rev 2017;38:343–352.
    1. Abd Aziz NAS, Teng N, Abdul Hamid MR, Ismail NH. Assessing the nutritional status of hospitalized elderly. Clin Interv Aging 2017;12:1615–1625.
    1. Suzuki D, Kobayashi R, Sano H, Hori D, Kobayashi K. Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance. Int J Hematol 2018;107:486–489.
    1. Ryan E, McNicholas D, Creavin B, Kelly ME, Walsh T, Beddy D. Sarcopenia and inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 2020;25:67–73.
    1. Lopez JJ, Cooper JN, Albert B, Adler B, King D, Minneci PC. Sarcopenia in children with perforated appendicitis. J Surg Res 2017;220:1–5.
    1. Cooper C, Fielding R, Visser M, van Loon LJ, Rolland Y, Orwoll E, et al. Tools in the assessment of sarcopenia. Calcif Tissue Int 2013;93:201–210.
    1. Boutin RD, Yao L, Canter RJ, Lenchik L. Sarcopenia: current concepts and imaging implications. AJR Am J Roentgenol 2015;205:W255–W266.
    1. Amini B, Boyle SP, Boutin RD, Lenchik L. Approaches to assessment of muscle mass and myosteatosis on computed tomography (CT): a systematic review. J Gerontol A Biol Sci Med Sci 2019;74:1671–1678.
    1. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010;211:271–278.
    1. Masuda T, Shirabe K, Ikegami T, Harimoto N, Yoshizumi T, Soejima Y, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014;20:401–407.
    1. Tsien C, Garber A, Narayanan A, Shah SN, Barnes D, Eghtesad B, et al. Post‐liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol 2014;29:1250–1257.
    1. van Vugt JLA, Levolger S, de Bruin RWF, van Rosmalen J, Metselaar HJ, Ijzermans JNM. Systematic review and meta‐analysis of the impact of computed tomography‐assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant 2016;16:2277–2292.
    1. Golse N, Octav Bucur P, Ciacio O, Pittau G, Sa Cunha A, Adam R, et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver Transpl 2016.
    1. Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, et al. Cut‐off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 2016;35:1557–1563.
    1. Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual‐energy X‐ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol 2015;27:328–334.
    1. Lurz E, Patel H, Frimpong RG, Ricciuto A, Kehar M, Wales PW, et al. Sarcopenia in children with end‐stage liver disease. J Pediatr Gastroenterol Nutr 2018;66:222–226.
    1. Mangus RS, Bush WJ, Kubal CA, Miller C. Severe sarcopenia and increased fat stores in pediatric patients with liver, kidney, or intestine failure. J Pediatr Gastroenterol Nutr 2017;65:579–583.
    1. Ziaaldini MM, Marzetti E, Picca A, Murlasits Z. Biochemical pathways of sarcopenia and their modulation by physical exercise: a narrative review. Front Med 2017;4:167.
    1. Bouchi R, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, et al. Association of sarcopenia with both latent autoimmune diabetes in adults and type 2 diabetes: a cross‐sectional study. J Diabetes Complications 2017;31:992–996.
    1. Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C, Zeghbi Cochenski Borba V. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr 2018;10:25.
    1. Kim K, Hong S, Kim EY. Reference values of skeletal muscle mass for Korean children and adolescents using data from the Korean National Health and Nutrition Examination Survey 2009‐2011. PLoS ONE 2016;11:e0153383.
    1. McCarthy HD, Samani‐Radia D, Jebb SA, Prentice AM. Skeletal muscle mass reference curves for children and adolescents. Pediatr Obes 2014;9:249–259.
    1. Harbaugh CM, Zhang P, Henderson B, Derstine BA, Holcombe SA, Wang SC, et al. Personalized medicine: Enhancing our understanding of pediatric growth with analytic morphomics. J Pediatr Surg 2017;52:837–842.
    1. Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score. World J Gastroenterol 2015;21:7637–7647.
    1. The Centers for Disease Control C . Overview of the CDC growth charts for use in the United States among children and teens aged 2 years to 20 years. 2015. [updated April 15, 2015. Available from: .
    1. Team RC . R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
    1. Kaido T. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013;13:1549–1556.
    1. Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013;19:1396–1402.
    1. Peterson SJ, Braunschweig CA. Prevalence of sarcopenia and associated outcomes in the clinical setting. Nutrition in clinical practice: official publication of the American Society for Parenteral and Enteral Nutrition 2016;31:40–48.
    1. Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte‐Rojo A, et al. A North American expert opinion statement on sarcopenia in liver transplantation. Hepatology 2019;70:1816–1829.
    1. Lai JC, Sonnenday CJ, Tapper EB, Duarte‐Rojo A, Dunn MA, Bernal W, et al. Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant 2019;19:1896–1906.
    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–M156.
    1. Wang J, Zou Y, Zhao J, Schneider DB, Yang Y, Ma Y, et al. The impact of frailty on outcomes of elderly patients after major vascular surgery: a systematic review and meta‐analysis. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery 2018;56:591–602.
    1. Uppal S, Igwe E, Rice LW, Spencer RJ, Rose SL. Frailty index predicts severe complications in gynecologic oncology patients. Gynecol Oncol 2015;137:98–101.
    1. Orsso CE, Tibaes JRB, Oliveira CLP, et al. Low muscle mass and strength in pediatrics patients: Why should we care?. Clin Nutr. 2019;38(5):2002–2015.
    1. Lurz E, Quammie C, Englesbe M, Alonso EM, Lin HC, Hsu EK, et al. Frailty in children with liver disease: a prospective multicenter study. J Pediatr 2018;194:109–15.e4.
    1. Safer U, Kaplan M, Binay SV. Evaluation of sarcopenia in children. J Surg Res 2019;237:112.
    1. Ooi PH, Amber H, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, et al. Sarcopenia in chronic liver disease: impact on outcomes. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019;25:1422–1438.
    1. Arbanas J, Pavlovic I, Marijancic V, Vlahovic H, Starcevic‐Klasan G, Peharec S, et al. MRI features of the psoas major muscle in patients with low back pain. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2013;22:1965–1971.
    1. Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Fontes P, et al. Objective radiologic assessment of body composition in patients with end‐stage liver disease: going beyond the BMI. Transplantation 2013;95:617–622.
    1. DiMartini A, Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B, Fox K, et al. Muscle mass predicts outcomes following liver transplantation. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013;19:1172–1180.
    1. Hoshikawa Y, Iida T, Ii N, Muramatsu M, Nakajima Y, Chumank K, et al. Cross‐sectional area of psoas major muscle and hip flexion strength in youth soccer players. Eur J Appl Physiol 2012;112:3487–3494.
    1. Hoshikawa Y, Muramatsu M, Iida T, Ii N, Nakajima Y, Kanehisa H. Sex differences in the cross‐sectional areas of psoas major and thigh muscles in high school track and field athletes and nonathletes. J Physiol Anthropol 2011;30:47–53.
    1. Shen W, Punyanitya M, Wang Z, Gallagher D, St‐Onge MP, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross‐sectional image. J Appl Physiol (1985) 2004;97:2333–2338.
    1. Byun SE, Kim S, Kim KH, Ha YC. Psoas cross‐sectional area as a predictor of mortality and a diagnostic tool for sarcopenia in hip fracture patients. J Bone Miner Metab 2019;37:871–879.
    1. Lacoste Jeanson A, Dupej J, Villa C, Bruzek J. Body composition estimation from selected slices: equations computed from a new semi‐automatic thresholding method developed on whole‐body CT scans. PeerJ 2017;5:e3302.
    1. Faron A, Luetkens JA, Schmeel FC, Kuetting DLR, Thomas D, Sprinkart AM. Quantification of fat and skeletal muscle tissue at abdominal computed tomography: associations between single‐slice measurements and total compartment volumes. Abdominal radiology (New York) 2019;44:1907–1916.
    1. Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep 2018;8:11369.
    1. Linder N, Schaudinn A, Langenhan K, Krenzien F, Hau HM, Benzing C, et al. Power of computed‐tomography‐defined sarcopenia for prediction of morbidity after pancreaticoduodenectomy. BMC Med Imaging 2019;19:32.
    1. Locke JE, Carr JJ, Nair S, Terry JG, Reed RD, Smith GD, et al. Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates. Clin Transplant 2017;31.
    1. Weig T, Irlbeck T, Frey L, Paprottka P, Irlbeck M. Above and beyond BMI: Alternative methods of measuring body fat and muscle mass in critically ill patients and their clinical significance. Anaesthesist 2016;65:655–662.
    1. Reid JG, Livingston LA, Pearsall DJ. The geometry of the psoas muscle as determined by magnetic resonance imaging. Arch Phys Med Rehabil 1994;75:703–708.
    1. Honkanen T, Mantysaari M, Leino T, Avela J, Kerttula L, Haapamaki V, et al. Cross‐sectional area of the paraspinal muscles and its association with muscle strength among fighter pilots: a 5‐year follow‐up. BMC Musculoskelet Disord 2019;20:170.
    1. Bureau USC. Population estimates, July 1, 2018, (V2018) [Available from: .
    1. Census , Statistics Canada Catalogue no. 98'316'X2016001 Ottawa, 2016, Released November 29, 2017. [Available from: Lang = E
    1. Rodd C, Sharma AK. Recent trends in the prevalence of overweight and obesity among Canadian children. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2016;188:E313–e20.
    1. Permuth JB, Clark Daly A, Jeong D, Choi JW, Cameron ME, Chen DT, et al. Racial and ethnic disparities in a state‐wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities. Cancer Med 2019;8:3314–3324.
    1. Crawford RJ, Elliott JM, Volken T. Change in fatty infiltration of lumbar multifidus, erector spinae, and psoas muscles in asymptomatic adults of Asian or Caucasian ethnicities. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2017;26:3059–3067.
    1. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003;51:1602–1609.
    1. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Hammad A, Tamai Y, et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition 2016;32:1200–1205.
    1. Tanaka NI, Murakami H, Ohmori Y, Aiba N, Morita A, Watanabe S, et al. Association of visceral fat area with abdominal skeletal muscle distribution in overweight Japanese adults. Obes Res Clin Pract 2018;12:378–383.
    1. Remigio‐Baker RA, Allison MA, Schreiner PJ, Carnethon MR, Nettleton JA, Mujahid MS, et al. Sex and race/ethnic disparities in the cross‐sectional association between depressive symptoms and muscle mass: the multi‐ethnic study of atherosclerosis. BMC Psychiatry 2015;15:221.
    1. Carey EJ, Lai JC, Sonnenday C, et al. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology. 2019;70(5):1816–1829.
    1. Morrell GR, Ikizler TA, Chen X, Heilbrun ME, Wei G, Boucher R, et al. Psoas muscle cross‐sectional area as a measure of whole‐body lean muscle mass in maintenance hemodialysis patients. J Ren Nutr 2016;26:258–264.
    1. Shen W, Punyanitya M, Wang Z, Gallagher D, St‐Onge MP, Albu J, et al. Visceral adipose tissue: relations between single‐slice areas and total volume. Am J Clin Nutr 2004;80:271–278.
    1. Alonso EM. Growth and developmental considerations in pediatric liver transplantation. Liver Transpl 2008;14:585–591.
    1. Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology 2014;60:362–398.
    1. Tandon P, Mourtzakis M, Low G, Zenith L, Ney M, Carbonneau M, et al. Comparing the variability between measurements for sarcopenia using magnetic resonance imaging and computed tomography imaging. Am J Transplant 2016;16:2766–2767.
    1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980‐2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 2014;384:766–781.
    1. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017. J Cachexia Sarcopenia Muscle 2017;8:1081–1083.

Source: PubMed

3
Předplatit